Thursday, Dec 7, 2023 · SEC filings
What the smart money revealed on Dec 7
456 insider filings came in. We hid 45 planned (10b5-1) sellers and 228 people whose filings were routine, like grants and tax withholding.
Golub Capital Direct Lending Unlevered Chairman Lawrence Golub bought $2M
133,389 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Pulse Biosciences (PLSE) Director Robert Duggan bought $617K
66,021 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 6 checked quarters beat the typical stock 6 months later.
National Storage Affiliates Trust (NSA) Vice Chairperson Arlen Nordhagen bought $359K
10,000 shares on the open market. Not a grant or an option exercise.
German American Bancorp (GABC) Director Thomas Seger bought $212K
7,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 5 checked quarters beat the typical stock 6 months later.
Rush Enterprises (RUSHA) CEO William Rush sold $65.3M
Not marked as a planned 10b5-1 sale. Sold 67% of the shares they held directly. Still holds 743,809 shares.
UnitedHealth Group (UNH) Director Stephen Hemsley sold $36.4M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 635,528 shares directly.
AAON Director Norman Asbjornson sold $6.34M
Not marked as a planned 10b5-1 sale. Sold 65% of the shares they held directly. Still holds 53,898 shares.
Show 35 more real buys
Show 105 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Dec 1–7
Open-market buys by officers and directors, filed in the 7 days up to Dec 7.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.